EPAS1 and polycythemia: Another scenario involves gain-of-function mutations in HIF-2α (c.1589C>T) leading to concurrent PPGL and polycythemia (118), as seen in the case of the germline mutation in exon 9 (c.1121T>A, p.F374Y), which predisposes patients to polycythemia and PGL development (119).